• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由间日疟原虫引起的致命性疟疾呼吸并发症。

A fatal respiratory complication of malaria caused by Plasmodium vivax.

机构信息

Instituto Nacional de Infectologia Evandro Chagas Fiocruz, Rio de Janeiro, Brazil.

Centro de Pesquisa, Diagnóstico e Treinamento em Malária da Fiocruz e da Secretaria de Vigilância em Saúde, Ministério da Saúde, Brasília, Brazil.

出版信息

Malar J. 2023 Oct 9;22(1):303. doi: 10.1186/s12936-023-04720-1.

DOI:10.1186/s12936-023-04720-1
PMID:37814260
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10563287/
Abstract

BACKGROUND

Malaria is endemic and represents an important public health issue in Brazil. Knowledge of risk factors for disease progression represents an important step in preventing and controlling malaria-related complications. Reports of severe forms of Plasmodium vivax malaria are now becoming a common place, but respiratory complications are described in less than 3% of global literature on severe vivax malaria.

CASE PRESENTATION

A severe respiratory case of imported vivax malaria in a previously healthy 40-year-old woman has been reported. The patient died after the fifth day of treatment with chloroquine and primaquine due to acute respiratory distress syndrome.

CONCLUSIONS

Respiratory symptoms started 48 h after the initiation of anti-malarial drugs, raising the hypothesis that the drugs may have been involved in the genesis of the complication. The concept that vivax malaria is a benign disease that can sometimes result in the development of serious complications must be disseminated. This report highlights, once more, the crucial importance of malaria early diagnosis, a true challenge in non-endemic areas, where health personnel are not familiar with the disease and do not consider its diagnosis promptly.

摘要

背景

疟疾在巴西流行,是一个重要的公共卫生问题。了解疾病进展的风险因素是预防和控制疟疾相关并发症的重要步骤。现在越来越多的报告提到了严重的间日疟原虫疟疾,但在全球关于严重间日疟的文献中,仅有不到 3%描述了呼吸道并发症。

病例介绍

报告了一例既往健康的 40 岁女性输入性间日疟严重呼吸道病例。该患者在接受氯喹和伯氨喹治疗 5 天后死于急性呼吸窘迫综合征。

结论

呼吸道症状在开始抗疟药物治疗后 48 小时出现,这提示药物可能参与了并发症的发生。间日疟原虫是一种良性疾病,但有时会导致严重并发症,这一概念必须得到传播。本报告再次强调了疟疾早期诊断的至关重要性,这在非流行地区是一个真正的挑战,因为那里的卫生人员不熟悉这种疾病,也不能及时诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d239/10563287/d723ece9f739/12936_2023_4720_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d239/10563287/d723ece9f739/12936_2023_4720_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d239/10563287/d723ece9f739/12936_2023_4720_Fig1_HTML.jpg

相似文献

1
A fatal respiratory complication of malaria caused by Plasmodium vivax.由间日疟原虫引起的致命性疟疾呼吸并发症。
Malar J. 2023 Oct 9;22(1):303. doi: 10.1186/s12936-023-04720-1.
2
The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis.氯喹治疗后有无伯氨喹治疗对间日疟原虫疟疾的血液学后果:全球抗疟药物耐药网络系统评价和个体患者数据荟萃分析。
BMC Med. 2019 Aug 1;17(1):151. doi: 10.1186/s12916-019-1386-6.
3
Acute respiratory distress syndrome due to vivax malaria: case report and literature review.间日疟所致急性呼吸窘迫综合征:病例报告及文献综述
Braz J Infect Dis. 2005 Oct;9(5):425-30. doi: 10.1590/s1413-86702005000500011. Epub 2006 Jan 6.
4
Atypical Plasmodium vivax malaria in a traveler: bilateral hydronephrosis, severe thrombocytopenia, and hypotension.一名旅行者的非典型间日疟原虫疟疾:双侧肾积水、严重血小板减少症和低血压。
J Travel Med. 2008 Mar-Apr;15(2):119-21. doi: 10.1111/j.1708-8305.2007.00178.x.
5
Severe acute respiratory distress syndrome secondary to Plasmodium vivax malaria.间日疟原虫疟疾继发的严重急性呼吸窘迫综合征
J Pak Med Assoc. 2016 Mar;66(3):351-3.
6
Disseminated intravascular coagulation presenting as symmetrical peripheral gangrene: a case report.以对称性外周坏疽为表现的弥散性血管内凝血:一例报告
J Med Case Rep. 2019 Jul 12;13(1):212. doi: 10.1186/s13256-019-2117-5.
7
Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.他非诺喹用于预防间日疟原虫疟疾患者复发。
Cochrane Database Syst Rev. 2020 Sep 6;9(9):CD010458. doi: 10.1002/14651858.CD010458.pub3.
8
Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.泰非诺喹与伯氨喹预防间日疟复发。
N Engl J Med. 2019 Jan 17;380(3):229-241. doi: 10.1056/NEJMoa1802537.
9
Imported malaria in the 1990s. A report of 59 cases from Houston, Tex.20世纪90年代的输入性疟疾。得克萨斯州休斯敦59例病例报告
Arch Fam Med. 1994 Feb;3(2):130-6. doi: 10.1001/archfami.3.2.130.
10
New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance.间日疟原虫疟疾的新进展:重症疾病与氯喹耐药性的上升
Curr Opin Infect Dis. 2009 Oct;22(5):430-5. doi: 10.1097/QCO.0b013e32832f14c1.

引用本文的文献

1
Computer Viewing Model for Classification of Erythrocytes Infected with spp. Applied to Malaria Diagnosis Using Optical Microscope.用于分类感染 spp. 的红细胞的计算机视觉模型。应用于使用光学显微镜的疟疾诊断。
Medicina (Kaunas). 2025 May 21;61(5):940. doi: 10.3390/medicina61050940.
2
Acetylsalicylic acid and dihydroartemisinin combined therapy on experimental malaria-associated acute lung injury: analysis of lung function and the inflammatory process.阿司匹林和双氢青蒿素联合治疗实验性疟疾相关急性肺损伤:肺功能和炎症过程分析。
Malar J. 2024 Sep 19;23(1):285. doi: 10.1186/s12936-024-05017-7.

本文引用的文献

1
Clinical impact of vivax malaria: A collection review.《 vivax 疟疾的临床影响:文献综述》。
PLoS Med. 2022 Jan 18;19(1):e1003890. doi: 10.1371/journal.pmed.1003890. eCollection 2022 Jan.
2
Analysis of a Routinely Used Commercial Anti-Chikungunya IgM ELISA Reveals Cross-Reactivities with Dengue in Brazil: A New Challenge for Differential Diagnosis?对一种常用的商业抗基孔肯雅热IgM酶联免疫吸附测定法的分析揭示了其在巴西与登革热的交叉反应性:这是鉴别诊断的新挑战?
Diagnostics (Basel). 2021 Apr 30;11(5):819. doi: 10.3390/diagnostics11050819.
3
Severe vivax malaria trends in the last two years: a study from a tertiary care centre, Delhi, India.
过去两年间严重的间日疟趋势:来自印度德里一家三级护理中心的研究。
Ann Clin Microbiol Antimicrob. 2020 Oct 30;19(1):49. doi: 10.1186/s12941-020-00393-9.
4
The risk of morbidity and mortality following recurrent malaria in Papua, Indonesia: a retrospective cohort study.印度尼西亚巴布亚复发性疟疾的发病和死亡风险:一项回顾性队列研究。
BMC Med. 2020 Feb 20;18(1):28. doi: 10.1186/s12916-020-1497-0.
5
Are respiratory complications of Plasmodium vivax malaria an underestimated problem?间日疟原虫疟疾的肺部并发症是否被低估了?
Malar J. 2017 Dec 22;16(1):495. doi: 10.1186/s12936-017-2143-y.
6
Insights into the Cytoadherence Phenomenon of : The Putative Role of Phosphatidylserine.关于细胞黏附现象的见解:磷脂酰丝氨酸的假定作用。
Front Immunol. 2017 Sep 20;8:1148. doi: 10.3389/fimmu.2017.01148. eCollection 2017.
7
Acute undifferentiated fever in India: a multicentre study of aetiology and diagnostic accuracy.印度急性未分化型发热:病因及诊断准确性的多中心研究
BMC Infect Dis. 2017 Oct 4;17(1):665. doi: 10.1186/s12879-017-2764-3.
8
Respiratory Complications of Malaria: Systematic Review and Meta-Analysis.疟疾的呼吸系统并发症:系统评价与荟萃分析
Am J Trop Med Hyg. 2017 Sep;97(3):733-743. doi: 10.4269/ajtmh.17-0131. Epub 2017 Jul 19.
9
Demographic and clinical profiles of Plasmodium falciparum and Plasmodium vivax patients at a tertiary care centre in southwestern India.印度西南部一家三级医疗中心的恶性疟原虫和间日疟原虫患者的人口统计学和临床特征。
Malar J. 2016 Nov 25;15(1):569. doi: 10.1186/s12936-016-1619-5.
10
Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900.重症间日疟:对1900年以来临床研究的系统评价和荟萃分析
Malar J. 2014 Dec 8;13:481. doi: 10.1186/1475-2875-13-481.